128 related articles for article (PubMed ID: 26743075)
1. Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer.
Bhat S; Kabekkodu SP; Noronha A; Satyamoorthy K
Biochimie; 2016 Feb; 121():298-311. PubMed ID: 26743075
[TBL] [Abstract][Full Text] [Related]
2. [Epigenetic alterations in cervical cancer progression].
Ríos-Romero M; Soto-Valladares AG; Piña-Sánchez P
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S212-7. PubMed ID: 26462519
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics and cervical cancer: from pathogenesis to therapy.
Fang J; Zhang H; Jin S
Tumour Biol; 2014 Jun; 35(6):5083-93. PubMed ID: 24554414
[TBL] [Abstract][Full Text] [Related]
4. Molecular targets of HPV oncoproteins: potential biomarkers for cervical carcinogenesis.
de Freitas AC; Coimbra EC; Leitão Mda C
Biochim Biophys Acta; 2014 Apr; 1845(2):91-103. PubMed ID: 24388872
[TBL] [Abstract][Full Text] [Related]
5. Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer.
Milutin Gašperov N; Sabol I; Planinić P; Grubišić G; Fistonić I; Ćorušić A; Grce M
PLoS One; 2015; 10(6):e0129452. PubMed ID: 26057381
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic alterations in cervical carcinogenesis.
Szalmás A; Kónya J
Semin Cancer Biol; 2009 Jun; 19(3):144-52. PubMed ID: 19429477
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer.
Verlaat W; Snijders PJF; Novianti PW; Wilting SM; De Strooper LMA; Trooskens G; Vandersmissen J; Van Criekinge W; Wisman GBA; Meijer CJLM; Heideman DAM; Steenbergen RDM
Clin Cancer Res; 2017 Jul; 23(14):3813-3822. PubMed ID: 28119363
[No Abstract] [Full Text] [Related]
8. Molecular mechanisms in progression of HPV-associated cervical carcinogenesis.
Gupta SM; Mania-Pramanik J
J Biomed Sci; 2019 Apr; 26(1):28. PubMed ID: 31014351
[TBL] [Abstract][Full Text] [Related]
9. High-resolution melting analysis of HPV-16L1 gene methylation: A promising method for prognosing cervical cancer.
Qiu C; Zhi Y; Shen Y; Gong J; Li Y; Li X
Clin Biochem; 2015 Sep; 48(13-14):855-9. PubMed ID: 25982893
[TBL] [Abstract][Full Text] [Related]
10. Global methylation silencing of clustered proto-cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPV.
Wang KH; Lin CJ; Liu CJ; Liu DW; Huang RL; Ding DC; Weng CF; Chu TY
Cancer Med; 2015 Jan; 4(1):43-55. PubMed ID: 25418975
[TBL] [Abstract][Full Text] [Related]
11. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.
Steenbergen RD; Ongenaert M; Snellenberg S; Trooskens G; van der Meide WF; Pandey D; Bloushtain-Qimron N; Polyak K; Meijer CJ; Snijders PJ; Van Criekinge W
J Pathol; 2013 Sep; 231(1):53-62. PubMed ID: 23674368
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of the relationship between microRNA‑124a, -34b and -203 gene methylation and cervical oncogenesis.
Botezatu A; Goia-Rusanu CD; Iancu IV; Huica I; Plesa A; Socolov D; Ungureanu C; Anton G
Mol Med Rep; 2011; 4(1):121-8. PubMed ID: 21461574
[TBL] [Abstract][Full Text] [Related]
13. Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade.
Bryant D; Tristram A; Liloglou T; Hibbitts S; Fiander A; Powell N
J Clin Virol; 2014 Jan; 59(1):24-9. PubMed ID: 24268385
[TBL] [Abstract][Full Text] [Related]
14. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic human papillomavirus imposes an instructive pattern of DNA methylation changes which parallel the natural history of cervical HPV infection in young women.
Leonard SM; Wei W; Collins SI; Pereira M; Diyaf A; Constandinou-Williams C; Young LS; Roberts S; Woodman CB
Carcinogenesis; 2012 Jul; 33(7):1286-93. PubMed ID: 22552403
[TBL] [Abstract][Full Text] [Related]
16. Aberrant DNA methylation of DLX4 and SIM1 is a predictive marker for disease progression of uterine cervical low-grade squamous intraepithelial lesion.
Sakane J; Taniyama K; Miyamoto K; Saito A; Kuraoka K; Nishimura T; Sentani K; Oue N; Yasui W
Diagn Cytopathol; 2015 Jun; 43(6):462-70. PubMed ID: 25614457
[TBL] [Abstract][Full Text] [Related]
17. Detection of methylation of the promoter region of the MAL and CADM1 genes by pyrosequencing in cervical carcinoma.
Mersakova S; Visnovsky J; Holubekova V; Nachajova M; Kudela E; Danko J; Lasabova Z
Neuro Endocrinol Lett; 2014; 35(7):619-23. PubMed ID: 25617886
[TBL] [Abstract][Full Text] [Related]
18. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
[TBL] [Abstract][Full Text] [Related]
19. Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer.
Chen YC; Huang RL; Huang YK; Liao YP; Su PH; Wang HC; Chang CC; Lin YW; Yu MH; Chu TY; Lai HC
Int J Cancer; 2014 Jul; 135(1):117-27. PubMed ID: 24310984
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
Bosch FX; Burchell AN; Schiffman M; Giuliano AR; de Sanjose S; Bruni L; Tortolero-Luna G; Kjaer SK; Muñoz N
Vaccine; 2008 Aug; 26 Suppl 10():K1-16. PubMed ID: 18847553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
